No ASX ETF holds Mayne Pharma (MYX) as of 15 Oct 2026. Over the last 3 months it fell 11.7%: on $10,000, −$1170. We explain 2 big moves in that time.
About MYX
- SectorHealth Care
- IndustryPharmaceuticals, Biotechnology & Life Sciences
- Size$208.0m
- Held by0 ETFs
- Big moves2 in 3M
Each dot is a move we explain. Tap one, or a row of Why it moved, to see what caused it.
Why it moved
- −5.7%10 Sep 2026· No Catalyst Found
MYX fell alongside a broad healthcare sector sell-off, with the ASX health index down 2.3% and 36 industry peers down a median 2.3% on the same day.
- +10.2%peak +11.3%3 Aug 2026· Sector Flow
MYX.AX rose sharply alongside a broad rally in the ASX healthcare sector, which gained over 2.3% on the same day, lifting sentiment across health-related stocks.
Held by 0 ETFs
No ETF we track holds MYX directly.
Other Health Care companies
- SHLSonic Healthcare47 ETFs
- RMDResMed44 ETFs
- CSLCSL Limited42 ETFs
- BDXBcal36 ETFs
- CSXCleanspace36 ETFs
- REGRegis Health33 ETFs
- TLXTelix Pharma32 ETFs
- SIGSigma Healthcare31 ETFs
Why did MYX fall 5.7% on 10 Sep 2026?
Mayne Pharma
MYX fell alongside a broad healthcare sector sell-off, with the ASX health index down 2.3% and 36 industry peers down a median 2.3% on the same day.
The healthcare sector index fell 2.29% and peer median was -2.32%, both directionally consistent with MYX's move, but MYX dropped 5.66% — roughly 2.5x the sector move — which is disproportionate and suggests a stock-specific factor is also at play. No company announcements, news, or other filings were found to explain the excess move, so sector flow can account for part of the decline but not the full magnitude. Confidence is kept low because the proportionality rule is borderline and the residual gap is substantial.
Written by a language model from the evidence below, and it can be wrong. Tell us and we will fix or remove it. General information only, not financial product advice. It does not consider your objectives, finances or needs. Past performance is not a guide to future performance.
Evidence
Company announcements
Sector / macro signals